title: Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial.
abstract: Fourty-five migraine without aura patients underwent a parallel double-blind trial aiming the comparison of the effects of propranolol 60 mg/day to flunarizine 10 mg/day and to propranolol 60 mg/day plus flunarizine 10 mg/day simultaneously. There were 3 groups, each one with 15 patients. After a 20-day-baseline period, each group received one kind of treatment during 120 days. Migraine index on propranolol was 23.4*, on flunarizine 18.7* and on both drugs 14.4*, mean frequency of attacks on propranolol was 1.26**, on flunarizine 1.2** and on both drugs 1.13** (*p < 0.05, **p < 0.01 compared to baseline) and global evaluation was reduced with all forms of treatment. It was not found statistical differences between groups, nevertheless there was a trend in the group using two drugs reaching lower values in migraine index, frequency of attacks and global evaluation. In individuals using flunarizine (alone or associated with propranolol) the therapeutic effect was largely maintained up to 45 days after drug withdrawal.
authors.affiliation: Departamento de Neurologia, Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), Brasil.
authors.forename: C A
authors.initials: CA
authors.lastname: Bordini
authors.forename: M A
authors.initials: MA
authors.lastname: Arruda
authors.forename: M C
authors.initials: MC
authors.lastname: Ciciarelli
authors.forename: J G
authors.initials: JG
authors.lastname: Speciali
mesh_terms: D000433:1-Propanol / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D004311:Double-Blind Method; D004338:Drug Combinations; D005260:Female; D005444:Flunarizine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*
chemical_list: D004338:Drug Combinations; D000433:1-Propanol; D005444:Flunarizine